fashion -WSS

fashion

author：hotspot 2025-09-30 01:15:04 - browse：89

Rod Nathan, Ali Urman, and Patrick Nosker on the 2024 Breakthrough Summit East stage. — From left, Rod Nathan, portfolio manager and partner of J. Goldman & Co.; ARK Invest senior analyst Ali Urman; and Patrick Nosker, director of research and partner at Affinity Asset Advisors, discuss biotech investment opportunities at the 2024 STAT Breakthrough Summit East. STAT

Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors see more good news on the horizon.

Driving the momentum? Economics 101.

Biotechs rely on borrowing capital, which is a more tenuous task when interest rates are high. But interest rates have most likely peaked, with Federal Reserve officials signaling earlier this week they expected to make three cuts this year. For public biotechnology startups that have been battered by the market in recent years, this is a very good thing, Rod Nathan, portfolio manager and partner of J. Goldman & Co., said on a panel at STAT’s Breakthrough Summit East in New York on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Illumina names Agilent executive as new CEO

WSS

What American doctors can learn from their Israeli counterparts

Caregivers of transplant patients call for more support, training

ALS advocates say criticism of new drugs misses bigger picture

Weighted lottery helped low

Amazon on where the company's health care bets are headed next

Three issues to watch in global health in 2024

hotspot

fashion

knowledge

In Memoriam: Notable people who died in 2023

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Affirmative action in medical school literally saved lives

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

The cancer drug shortage isn’t new — and neither are the solutions

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

State Dept. review finds Biden bears some blame for Afghanistan failures

As JPM 2024 winds down, some health tech firms project optimism

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A new House health package & hospitals’ new site

hotspot

The nurse manager staffing crisis is hurting patients

What American doctors can learn from their Israeli counterparts

A rare thyroid diagnosis led to unexpected, all

What drug price negotiations mean for Medicare Part D

Covid hospitalizations on the rise, Humana says

What American doctors can learn from their Israeli counterparts

hotspot

explore

hotspot

hotspot